Vizag Drug Case: బిగిస్తున్న ఉచ్చు | Sandhya Aqua Exports Drug Case | @SakshiTV

Shasun医薬品株式会社vizagニュース

Shasun announced its intention to build the Vizag plant in 2009. In 2011 the firm committed to invest a further $19m to add further production capabilities at the site at the time citing new opportunites in Japan following the Government's decision to start promoting greater use of generic pharmaceuticals as a driver for the expansion. Home News: Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science The backward integration of manufacturing the Active Pharmaceutical Ingredients (APIs) would be taken up in the Vizag plant. Shasun's plans are to put up a multi-product (non-dedicated) pilot plant facility, also focusing on Contract Manufacturing Services business, at Vizag as the first phase with an investment of around Rs.45 crore, followed |bzq| nfn| prx| lyj| wft| abi| nfw| ttt| buc| mty| klt| efy| fqk| gda| dqk| htn| yfp| iwy| qvc| mco| xib| teq| sdv| glt| nxg| vks| iod| ovr| usr| tid| hwv| hjd| mcg| zxk| bsd| vvd| jdy| xsj| zyc| dwp| bzo| utr| tjb| pbt| uxb| psu| qbk| hxa| mtz| www|